Abstract
Quality Assurance and Quality Control, Part 2
Author(s): Akers Michael J
Issue: May/Jun 2015 - Volume 19, Number 3
Page(s): 215-221
Abstract
The tragedy surrounding the New England Compounding Center and contaminated steroid syringe preparations clearly points out what can happen if quality-assurance and quality-control procedures are not strictly practiced in the compounding of sterile preparations. This article is part 2 of a two-part article on requirements to comply with United States Pharmacopeia general chapters <797> and <1163> with respect to quality assurance of compounded sterile preparations. Part 1 covered documentation requirements, inspection procedures, compounding accuracy checks, and part of a discussion on bacterial endotoxin testing. Part 2 covers sterility testing, the completion from part 1 on bacterial endotoxin testing, a brief discussion of United States Pharmacopeia <1163>, and advances in pharmaceutical quality systems.
Related Keywords
- compounded sterile preparations
- contamination
- United States Pharmacopeia Chapter <1163>
- United States Pharmacopeia Chapter <797>
- USP
- quality assurance
- sterility testing
- bacterial endotoxin testing
- pharmaceutical quality sysstems
- injectables
- drug safety
- microorganisms
- finished preparation release checks
- fluid thioglycollate medium
- trypticase soy broth medium
- membrane filtration sterility testing
- pyrogens
- limulus amebocyte lysate test
- quality by design
Related Categories
- LEGAL
- STERILE PREPARATIONS
- SUPPORT
- QUALITY CONTROL
- UNITED STATES PHARMACOPEIA CONVENTIONS